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A 65 year old black woman with hypertension (HTN),
gastroesophageal reflux disease (GERD), and anxiety had
complained to her primary care physician of vague
abdominal pain.  Initial empiric treatment as an
outpatient for worsening GERD was unsuccessful.  The
patient had insidious development of generalized fatigue,
early satiety, nausea, vomiting, and weight loss.  An
ultrasound of the abdomen revealed multiple liver
lesions, with the largest lesion being 2.5 cm x 2.5 cm.
She subsequently underwent a CT scan of the abdomen
and pelvis, which confirmed multiple hyperdense liver
lesions.  The remainder of the scan was unremarkable.
Esophagogastroduodenoscopy (EGD) as well as
colonoscopy was performed, revealing a duodenal mass
and a sigmoidal polyp.  Biopsy of these two lesions
showed an adenomatous polyp and a tubular adenoma,
respectively, and subsequent liver biopsy diagnosed
poorly differentiated adenocarcinoma.  The patient was
then admitted to TJUH for further management.
Past medical and surgical history included HTN,
GERD, anxiety, and total hysterectomy. She had no
known drug allergies.  The patient denied current or
prior use of tobacco, alcohol, and illicit drugs.  She was a
retired first grade teacher.  Her family history was
significant only for coronary artery disease and
hypertension.
Her outpatient medications included metoprolol,
fosinopril, valsartan, atorvastatin, lansoprazole,
lorazepam, and Percocet.  
Review of systems was significant for lack of urinary
symptoms, changes in bowel habits, recent skin changes,
dysphagia, cough, or shortness of breath.  She also denied
fevers, chills, and sweats.  However, her sister felt that
the patient recently began having intermittent episodes
of confusion and new speech difficulties.
The patient was afebrile with a temperature of 97.7˚F,
blood pressure of 146/73 mm Hg, pulse of 90/min, and
respiratory rate of 22/min.  Head and neck exam was
unremarkable.  Cardiac examination revealed a regular
rate and rhythm with no murmurs, rub, or gallops.  Her
lungs were clear to auscultation.  Palpation of the
abdomen revealed a 3cm x 3cm mobile tender mass in
the right lower quadrant.  Bowel sounds were present
and normal.  Rectal examination revealed normal tone
and brown stool that was hemoccult positive.  Her
extremities were non-edematous, and her skin without
rashes or changes in pigmentation.  Neurologic
examination was significant for a right homonymous
hemianopsia.  The remainder of her cranial nerves were
intact.  Reflexes were equal and symmetric.  No pronator
drift or Babinski sign was identified.  Her strength was
5/5 in all extremities. A mini-mental status exam revealed
difficulty with repetition and naming, as well as
perseveration.  
The results of her blood work are listed in Table 1. A
repeat computerized tomographic (CT) scan of the
thorax, abdomen, and pelvis was performed, which
revealed bibasilar atelectasis without effusion or
lymphadenopathy.  CT of the abdomen and pelvis
showed numerous variable- sized lesions in both lobes of
the liver, bilateral wedge shaped infarcts in the kidneys,
and a right common femoral vein thrombus.  The
remainder of the abdomen and pelvis was unremarkable.
Magnetic resonance imaging (MRI) of the head revealed
multiple areas of infarction (Figure 1).  Both cerebral
hemispheres were involved, primarily involving the
distribution of the left posterior cerebral artery (PCA)
and left middle cerebral artery (MCA).  Magnetic
resonance angiography (MRA) of the head was negative
for vascular abnormalities.
The patient underwent transthoracic echocardiography,
which showed dynamic left ventricular function, dilated
right ventricle with hypokinesis, mild mitral
regurgitation, moderate tricuspid regurgitation, and
severe pulmonary hypertension with a RV-RA gradient
of 50 mmHg.  Also noted on echocardiography were
vegetations on the anterior and posterior leaflets of the
mitral valve.  Further serologic studies were performed
and the results are shown in Table 2.  Three sets of blood
cultures failed to grow an organism.  
Differential Diagnosis
The differential diagnosis for this patient was made for
thrombosis and thromboembolic phenomena.  Ideally, a
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unifying diagnosis should explain both the deep venous
thrombosis (DVT) as well as the multiple cerebral and
renal infarctions suffered by the patient.  The differential
diagnosis list for thrombotic disorders is lengthy and is
beyond the scope of this article, but includes coagulation
factor disorders or deficiency, impaired clot lysis,
malignancy, myeloproliferative disorders, hyperviscosity
states, antiphospholipid syndrome, thrombotic thrombo-
cytopenic purpura, disseminated intravascular
coagulation, and many others.  This extensive list can be
shortened, given several facts about this case.  First, the
cerebral and renal infarctions are most likely due to
embolic phenomena, rather than in-situ thrombosis.
Second, vegetations were identified on echocardiogram.
Third, there was no supporting evidence by personal or
family history that the patient would be harboring a
genetic defect predisposing her to thrombosis.  The
patient’s major risk factor for DVT and venous
thrombosis was her adenocarcinoma.  Historically,
mucin-producing neoplasms have offered the greatest
risk for thromboembolic complications.   This is the
most likely reason for her DVT.  But how do we explain
the multiple infarctions in the arterial system?  The
distribution of the areas of infarct is typical of an embolic
mechanism, with the heart the most likely source.
However, one must consider the possibility of
paradoxical embolism , atrial myxoma, and tumor
emboli.  Paradoxical embolism is unlikely in this case, as
no pulmonary emboli were suspected or identified.
While a patent foramen ovale may allow venous
thrombotic fragments to enter the arterial circulation, it
would not preclude pulmonary emboli to occur.  Thus
one would expect to find at least several pulmonary
emboli, given the high number of arterial emboli seen.
Tumor emboli are most commonly seen with lung
cancers entering the pulmonary venous system and
embolizing systemically.  In our patient, no atrial
myxoma or primary tumor could be found, though a
gastrointestinal primary was most likely.  Since the
echocardiogram revealed vegetations on the mitral valve,
these are the most likely source of the patient’s systemic
infarctions.  No organism was recovered from blood
cultures, and the patient remained clinically stable,
without fevers or hemodynamic compromise, even
without administration of antibiotics.  The constellation
of metastatic adenocarcinoma, DVT, valvular
vegetations, embolic phenomena, and negative blood
cultures lead to the diagnosis of marantic endocarditis.
Discussion 
Marantic endocarditis is known by many names,
including nonbacterial thrombotic endocarditis (NBTE),
degenerative verrucal endocarditis, terminal endocarditis,
endocardiosis, and endocarditis simplex.  Classically,
NBTE has been associated with cancer.  It has been
reported in association with almost every cancer, with
the exception of brain cancer.  Over 50% of NBTE cases
are associated with malignant neoplasms.  The most
commonly associated cancers with NBTE are pancreas
and lung.   Many nonneoplastic diseases are also
associated with NBTE, albeit a much smaller percentage
of cases.  These include rheumatic heart disease, systemic
lupus erythematosus, ulcerative fibrosis, membranopro-
liferative glomerulonephritis, polyarteritis nodosa, and
many others.   NBTE has also been associated with
disseminated intravascular coagulation (DIC), and their
pathologic mechanisms have been thought to be similar.  
There is no gender bias for development of NBTE.  It is
seen more commonly in patients during the fourth
through eighth decades of life.  However, it has been seen
in all ages, including infants and children.  The finding
of NBTE, though rare in the living, has been estimated
at 0.3% up to 9.3% of autopsies.   
The pathogenesis of NBTE has been theorized to require
valvular irregularity, with subsequent thrombus
formation on the irregular valve surface.  The valve often
appears grossly normal.  This results in a nonbacterial or
sterile vegetation that also lacks inflammatory changes.
Such a mechanism helps to explain the development of
NBTE in patients with pulmonary artery catheters.   The
vegetations seen with catheter placement generally occur
after 4 days duration of catheterization, and most likely
involve the right sided valves.  This is in contrast to
noncatheter associated NBTE, which mostly develops
on left sided valves.  The aortic valve is affected slightly
more often than the mitral valve (39.3% vs. 37.3%).  
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It is often difficult to identify NBTE due to lack of
symptoms until embolism occurs.  Embolic phenomena
occur in approximately 42% of cases, with a reported
range of 14% to 91%.  The higher rates of embolism are
seen in neoplasm-associated NBTE.  Cerebral infarction
is the most common (80%), followed by renal and splenic
injury.   However, myocardial, mesenteric, extremity, and
skin infarctions may also be seen.  Patients with embolic
complications secondary to NBTE are often
asymptomatic, though they may develop chest pain,
abdominal pain, mental status changes, and hematuria.  
Valvular dysfunction can also occur with NBTE, but it
is not known whether valvular dysfunction leads to
vegetation formation, or if vegetations cause valvular
dysfunction.  Most often, surgery is indicated to repair
and/or replace the dysfunctional valve, at which time
NBTE is frequently diagnosed. 
Diagnosis
Diagnosis of NBTE is based on historical and clinical
findings.  M-mode echocardiography has not been
proven to be useful in diagnosing NBTE, because many
vegetations may be less than 2mm in size and easily
missed. Also vegetations are composed only of platelets
and fibrin, and may  easily and completely dislodge with
embolization.  It is important to eliminate infectious
endocarditis (IE) as an etiology.  Blood cultures should
be drawn, and special media and prolonged incubation
used, if culture-negative endocarditis is suspected.  Head
imaging with angiography is important, since mycotic
aneurysms complicate 4% to 10% of IE cases.   Mycotic
aneurysms may be found in any vessel, though tend to
involve the distal middle cerebral artery, and are multiple
and bilateral.   The overall mortality of patients with a
mycotic aneurysm is 60% and rises to 80% with rupture.
Risk of rupture is increased with anticoagulation therapy,
as is risk for intracerebral hemorrhage (ICH) with
cardioembolic strokes. 
Treatment
There is no proven effective treatment for NBTE.  Once
NBTE and DIC were felt to represent different entities
on a clinical spectrum, and that treatments beneficial for
DIC would also treat NBTE.  No trials of anticoagu-
lation with heparin or warfarin have shown benefit in
treating NBTE, despite theories that anticoagulation
would prevent platelet and fibrin deposition on valves.6
Management of NBTE involves symptomatic and
supportive therapy.
In our patient, the risk of anticoagulation for DVT had
to be weighed against the risk of ICH after embolic
strokes.  It was felt that the benefit of anticoagulation for
DVT far outweighed the risk of ICH, and the patient
was begun on enoxaparin injections.
Table 1. Initial Laboratory Values
Laboratory Result Normal Units
WBC 19.2 4-11 103 cells/cm3
Neutrophils 81 40-73 %
Bands 8 0-9 %
Lymphocytes 5 20-44 %
Hgb 9.1 12.5-15 g/dL
Platelets 227 140-400 103 cells/cm3
Reticulocytes 4 0.5-1.5 %
Na 142 135-146 mmol/L
K 3.6 3.5-5.0 mmol/L
Cl 103 98-109 mmol/L
HCO3 24 24-32 mmol/L
BUN 17 7-26 mg/dL
Creatinine 0.9 0.7-1.4 mg/dL
Glucose 145 60-110 mg/dL
iCa 4.5 4.5-5.3 mg/dL
Mg 2.1 1.3-2.1 mg/dL
PO4 3.5 2.5-4.5 mg/dL
Protein 6.8 6.0-8.5 g/dL
Albumin 3.3 3.2-4.9 g/dL
AST 68 7-35 IU/L
ALT 48 1-30 IU/L
Alk. Phos. 607 25-120 IU/L
Bilirubin, Total 3.1 0.2-1.2 mg/dL
Bilirubin, Direct 1.3 0.0-0.4 mg/dL
LDH 347 100-200 IU/L
Ammonia 46 11-35 mcmol/L
Haptoglobin 380 16-200 mg/mL
Iron 26 40-155 mcg/dL
TIBC 250 250-400 mcg/dL
Ferritin 925 10-160 ng/mL
INR 1.55 0.91-1.09 N/A
PTT 35 25-37 sec
TSH 0.34 0.4-4.8 mIU/mL
FT4 1.3 0.7-1.6 ng/dL
FT3 227 230-420 pg/L
B12 2826 200-900 pg/mL
Folate 9.1 3-18 ng/mL
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Table 2
Laboratory Result Normal Units
DRVVT 41.2 21.1-36.7 sec
Mix DRVVT 1.05 <1.12 N/A
HBsAg Neg Neg N/A
HBsAb Neg N/A N/A
HBcAb Pos Neg N/A
HCAb Neg Neg N/A
RPR Neg Neg N/A
CEA 16.9 0-5 ng/mL
CA125 2366.7 0-35 U/mL
AFP 5.0 0.0-6.4 IU/mL
CA19-9 110 0-37 U/mL
Figure 1. MRI Head.  
Note the multiple infarcts located in both cerebral
hemispheres.
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